Therapeutic effects of Medicago sativa against cyclophosphamide-induced toxicity in rats

Objective: Medicago sativa (M. sativa) has been traditionally used for treating anemia; therefore, M. sativa hydro-ethanolic extract therapeutic effects against cyclophosphamide (CP) -induced hematologic and liver toxicity were examined. Materials and Methods: Thirty male Wistar rats were randomly d...

詳細記述

保存先:
書誌詳細
主要な著者: Vajihe Rouki (著者), Mohammad Hossein Boskabady (著者), Narges Marefati (著者), Reyhaneh Sotoudeh (著者), Zahra Gholamnezhad (著者)
フォーマット: 図書
出版事項: Mashhad University of Medical Sciences, 2024-01-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b8c34a8e8f4e4100a43b8734d073f8e4
042 |a dc 
100 1 0 |a Vajihe Rouki  |e author 
700 1 0 |a Mohammad Hossein Boskabady  |e author 
700 1 0 |a Narges Marefati  |e author 
700 1 0 |a Reyhaneh Sotoudeh  |e author 
700 1 0 |a Zahra Gholamnezhad  |e author 
245 0 0 |a Therapeutic effects of Medicago sativa against cyclophosphamide-induced toxicity in rats 
260 |b Mashhad University of Medical Sciences,   |c 2024-01-01T00:00:00Z. 
500 |a 2228-7930 
500 |a 2228-7949 
500 |a 10.22038/ajp.2023.22911 
520 |a Objective: Medicago sativa (M. sativa) has been traditionally used for treating anemia; therefore, M. sativa hydro-ethanolic extract therapeutic effects against cyclophosphamide (CP) -induced hematologic and liver toxicity were examined. Materials and Methods: Thirty male Wistar rats were randomly divided to control (saline); CP (100 mg/kg, day 1-3, subcutaneously); CP+ M. sativa 200 mg/kg (MS 200); CP+ M. sativa 400 mg/kg (MS 400); CP+ dexamethasone (0.1 mg/kg), (all groups n=6). Treated animals received M. sativa or dexamethasone by gavage from days 7-14. On days 0, 7, and 14, hematologic parameters, and on the 14th day, serum and liver tissue oxidative stress markers including nitric oxide, malondialdehyde (MDA) and total thiol levels, superoxide dismutase (SOD) and catalase (CAT) activities, serum lipids, and liver enzymes were measured.Results: Animal weight, platelet, white blood cells, and red blood cells counts, hemoglobin and hematocrit as well as thiol, SOD, and CAT activities in serum and liver tissue were significantly reduced, but serum nitric oxide, MDA, total cholesterol, triglycerides, low-density lipoproteins levels, and liver enzymes were increased in the CP group compared to the control group (p<0.05 to p<0.001). Administering M. sativa extract (400 mg/kg) significantly enhanced platelet count, and SOD and CAT activities and inhibited all of the CP toxic effects, while dexamethasone improved platelet count and oxidative stress markers compared to the CP group (p<0.05 to p<0.001).Conclusion: The extract of M. sativa (400 mg/kg) showed therapeutic effects against the CP-induced myelosuppression and thrombocytopenia and improved oxidative stress markers which were comparable to the effect of dexamethasone. 
546 |a EN 
690 |a cyclophosphamide 
690 |a medicago sativa 
690 |a myelosuppression 
690 |a thrombocytopenia 
690 |a oxidative stress 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Avicenna Journal of Phytomedicine, Vol 14, Iss 1, Pp 112-125 (2024) 
787 0 |n https://ajp.mums.ac.ir/article_22911_f2f13b47a6a02f1b8ded6de0bf0994b1.pdf 
787 0 |n https://doaj.org/toc/2228-7930 
787 0 |n https://doaj.org/toc/2228-7949 
856 4 1 |u https://doaj.org/article/b8c34a8e8f4e4100a43b8734d073f8e4  |z Connect to this object online.